HCV launch

[Anonymous]

You cannot pull a gun in league play Donny.

 

[Anonymous]

Have faith that we will receive approval and there will still be plenty of patients for 3D! The World's Most Interesting Man

 

[Anonymous]

Have faith that we will receive approval and there will still be plenty of patients for 3D! The World's Most Interesting Man

We are dead in the water if we dont price our 3D combo right. Why in the world would a doctor rx our therapy over Harvoni? If you had HCV, ask yourself, which therapy would you want?

 

[Anonymous]

So the expected goal for Viekira is a 51% share. What do you think? Is this realistic? What do you think our actual share will be in 2015?

 

[Anonymous]

So the expected goal for Viekira is a 51% share. What do you think? Is this realistic? What do you think our actual share will be in 2015?

No geno 2 or 3 scripts. That leaves 70% of market if you killed it you would have a 35% share. So 12% national avg by next summer

 

[Anonymous]

We are dead in the water if we dont price our 3D combo right. Why in the world would a doctor rx our therapy over Harvoni? If you had HCV, ask yourself, which therapy would you want?

You must have faith, my little one! The World's Most Interesting & Intelligent Man

 

[Anonymous]

My MSL said she's expecting approval at the end of the day.

 

[Anonymous]

You must have faith, my little one! The World's Most Interesting & Intelligent Man

you mean 1/2 a man

 

[Anonymous]

Approval in Europe! US today!!! Let's SELL!!!!!!!

 

[Anonymous]

Approval in Europe! US today!!! Let's SELL!!!!!!!

We were NOT approved in the EMA today. We received a "positive opinion" from the EMA agency and they will render a decision in the first quarter of 2015. Approval in the US will not come today either. You have nothing to sell yet (except Moderiba and Orasure).

 

[Anonymous]

We were NOT approved in the EMA today. We received a "positive opinion" from the EMA agency and they will render a decision in the first quarter of 2015. Approval in the US will not come today either. You have nothing to sell yet (except Moderiba and Orasure).

Orasure is not a product. It's a company you r*****.

 

[Anonymous]

Approval in Europe! US today!!! Let's SELL!!!!!!!

I thought you said we would receive approval YESTERDAY!!!

 

[Anonymous]

I thought you said we would receive approval YESTERDAY!!!

Anyone! Crickets

 

[Anonymous]

Anyone! Crickets

My manager keeps telling us any day so maybe it will be next week. Either way we will be the preferred brand that's easy to get!

 

[Anonymous]

My manager keeps telling us any day so maybe it will be next week. Either way we will be the preferred brand that's easy to get!

"Preferred brand" lol! Wow,you are delusional!

 

[Anonymous]

My manager keeps telling us any day so maybe it will be next week. Either way we will be the preferred brand that's easy to get!

Well if your managers says that it must be true.

 

[Anonymous]

How was Orlando?

 

[Anonymous]

Late February 2015 in Buffalo, NY.

 

[Anonymous]

My manager keeps telling us any day so maybe it will be next week. Either way we will be the preferred brand that's easy to get!

Approval will not be much before the December 21st PDUFA date. Possibly the 19th.

 

[Anonymous]

Only 6% of patients experienced anemia across the Phase 3 program (2,300 patients). It's really not a big deal and easily managed with RBV dose reduction.

anemia dependent upon what the baseline Hb levels were. Start with higher levels in clinical trials (13-M, 12-F) than what is seen in real-world population and have 2gm/dL drop and won't have it drop below what is considered anemia in HCV trial (less than 10). We'll see what happens when patients with baseline lower than 13 or 12 start on a RBV containing regimen